glp 1 drugs insurance coverage CMS Issues Guidance on GLP-1 Anti-Obesity What Is Insurance Prior Authorization
Description
Pr P.-N
The market is expanding at a CAGR of 5.14% between 2024 and 2034
The use of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of obesity is a fairly recent phenomenon
10.1016/j.rbmo.2017.03.023 Reprod Biomed Online
Many insurance plans cover GLP-1s for other FDA-approved conditions, even if they dont cover them for weight loss alone
PMID 27092049
